
Sourced report
Source9 months ago
There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal. ...
1 min briefingRead signal →
4 premium articles in this collection

In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal. ...

Campaigners say the company is contributing to rising rates of childhood obesity, while the firm says it is helping to combat malnutritionNestlé is still adding sugar to most baby cereals so...

Exclusive: Scientists from UNSW school of chemistry analyse sample of treatment, bought online and purported to mimic effects of Ozempic, and find nothing more than saline solution...

Swapping foods like premade lasagna for hand-made spaghetti Bolognese made a difference. ...